The invention

The invention
Fc-engineered CD9 antibodies for blood cancers

Fc-engineered CD9 antibodies for blood cancers

The invention

Name of invention
Fc-engineered CD9 antibodies for blood cancers
Anticorps CD9 modifiés Fc pour les cancers du sang

Invention description

Description
New prototypes of therapeutic CD9 antibody are generated by Fc engineering with potent activities against refractory leukemia and excellent safety profiles. Toxicity of CD9 antibodies, a longstanding hurdle for clinical translation, is resolved.

Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.